![]() |
市場調査レポート
商品コード
1297824
等温核酸増幅技術の世界市場-2023年~2030年Global Isothermal Nucleic Acid Amplification Technology Market - 2023-2030 |
||||||
カスタマイズ可能
適宜更新あり
|
等温核酸増幅技術の世界市場-2023年~2030年 |
出版日: 2023年06月15日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
|
世界の等温核酸増幅技術市場は、2022年に33億米ドルに達し、2030年には75億米ドルに達することで有利な成長を示すと予測されています。等温核酸増幅技術市場は、予測期間2023-2030年に11.1%のCAGRを示すと予測されています。
等温核酸増幅は、一定の温度で素早く効果的に核酸系列を収集する技術です。核酸増幅技術は、分子生物学や組み換えDNAアプローチで採用されています。これらの方法は、短い数の核酸を同定・調査する際のトッププラクティスとして採用されています。
感染症の世界の有病率の増加が、予測期間中の世界の等温核酸増幅技術(INAAT)市場の成長を牽引しています。例えば、世界保健機関は、2022年10月24日から2022年11月23日の間に5,000人以上の新鮮なサル痘患者を登録しました。さらに、2021年末には、米国大統領エイズ対策緊急計画によるHIVケアと治療のためのCDCの援助により、1,170万人以上が抗レトロウイルス治療(ART)を受けています。
老年人口の増加は、世界の等温核酸増幅技術市場に今後数年間の有望な成長機会をもたらしています。例えば、国連の「World Population Prospects 2022」によると、80歳以上の人口は2022年の1億5700万人から2050年には3倍の4億5900万人に増加すると予測されています。
COVID-19の分析には、COVID前シナリオ、COVIDシナリオ、COVID後シナリオが含まれ、価格力学(COVID前シナリオと比較したパンデミック中およびパンデミック後の価格変動を含む)、需給スペクトラム(取引制限、封鎖、およびその後の問題による需要と供給のシフト)、政府の取り組み(政府機関による市場、セクター、産業を活性化させる取り組み)、メーカーの戦略的取り組み(COVID問題を緩和するためにメーカーが行ったことをここで取り上げる)が含まれます。
WHOはロシアの攻撃開始以来、医療インフラに対する703件の攻撃を記録しています。さらに、ロシア軍が隣国ウクライナの中心部まで侵攻しているため、アルミニウム、銅、鉄鋼、プラスチックといった主要原材料のコストが、一般的なインフレとは別に、白物家電のさらなるコスト上昇を招いています。しかし、戦争にもかかわらず、ウクライナは患者に必要な医療サービスを提供し続けています。
過去の金融不況時に医療機関が解雇や雇用を考えたように、ヘルスケア業界は不況と完全に無縁ではないです。とはいえ、この業界はその本質的な性質から、他のセクターよりはうまく対処しています。しかし、インフレが続く中、景気後退の危機は市場を脅かしています。
世界の先進諸国における高インフレは、過去2年間にわたる一般的なコスト高騰となって表れており、景気後退の持続に対する緊張の高まりが高まっています。一般的な購買力の累積的な悪化は、特に成長経済に影響を与えると予想され、多くの点で有用であると考えられています。
人工知能は今後数年間、世界の等温核酸増幅市場にプラスの影響を与えると推定されます。人工知能(AI)とモノのインターネット(IoT)技術(AIoT)の組み合わせは、2世紀前に最初の商業用製氷機が発明されて以来、等温核酸増幅にとって最大の破壊となるかもしれないです。
The Global Isothermal Nucleic Acid Amplification Technology Market reached USD 3.3 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 7.5 billion by 2030. the isothermal nucleic acid amplification technology market is expected to exhibit a CAGR of 11.1% during the forecast period 2023-2030.
Isothermal nucleic acid amplification is a technique that quickly and effectively collects nucleic acid series at a consistent temperature. Nucleic acid amplification technologies are employed in molecular biology and recombinant DNA approaches. These methods are employed as top practices in identifying and investigating a short number of nucleic acids.
The growing prevalence of infectious diseases globally is driving the global isothermal nucleic acid amplification technology (INAAT) market growth during the forecast period. For instance, the World Health Organization registered over 5,000 fresh monkeypox patients between October 24, 2022 to November 23, 2022. Moreover, at the end of 2021, over 11.7 million individuals were on Anti Retroviral Treatment (ART) outcome of the CDC's aid for HIV care and treatment via the U.S. President's Emergency Plan for AIDS Response.
The growing geriatric population is presenting the global isothermal nucleic acid amplification market with prospective growth opportunities in the upcoming years. For instance, according to the World Population Prospects 2022, from the UN, the number of individuals aged 80 or above is anticipated to grow triple fold, from 157 million in 2022 to 459 million by 2050.
The COVID-19 analysis includes Pre-COVID Scenario, COVID Scenario, and Post-COVID Scenario along with Pricing Dynamics (Including pricing change during and post-pandemic comparing it to pre-COVID scenarios), Demand-Supply Spectrum (Shift in demand and supply owing to trading restrictions, lockdown and subsequent issues), Government Initiatives (Initiatives to revive market, sector or Industry by Government Bodies) and Manufacturers Strategic Initiatives (What manufacturers did to mitigate the COVID issues will be covered here).
The war has negatively impacted the global isothermal nucleic acid amplification market to a slight extent as the WHO has recorded 703 attacks on health infrastructure since Russia's attack started. Moreover, as Russian armed forces progress deeper into the heart of neighboring Ukraine, costs of key raw materials such as aluminum, copper, steel and plastic, separated from general inflation, are currently threatening additional cost escalation for white goods commodities. However, despite the War, Ukraine continues to provide necessary health services to patients.
The healthcare industry is not completely immune to recession, as healthcare institutions thought firings and employment during past financial downturns. That stated, the industry does cope finer than other sectors because of its essential nature. However, the danger of recession threatens the market as inflation persists increasing.
The elevated extent of tension about the persistent recession as the high inflation in developed countries worldwide has transpired in a general cost surge over the past two years. The cumulatively deteriorating general purchasing control is anticipated to affect growing economies particularly and is considered helpful in numerous ways.
Artificial intelligence is estimated to have a positive impact on the global isothermal nucleic acid amplification market in the upcoming years. The combination of artificial intelligence (AI) and Internet of Things (IoT) technology (AIoT) may be the biggest disruption to the isothermal nucleic acid amplification since the invention of the first commercial ice-making machine two centuries ago.
The Loop-mediated Isothermal Amplification (LAMP) Technology Type Segment is Expected to Hold a Dominant Position in the Market Over the Forecast Period.
Loop-mediated Isothermal Amplification (LAMP) is estimated to hold 28.6% of the market share by 2030 owing to the increasing product introductions into the market. For instance, in March 2022, Thermo fisher scientific, an American supplier of scientific instrumentation, reagents and consumables and software services, introduced two new reverse transcription loop-mediated isothermal amplification-based developments that deliver a rapid and inexpensive technique for identifying viral pathogens.
Owing to the increasing number of cancer deaṭhs and growing efforts to fight against cancer Europe is estimated to hold around 25.9% of the global isothermal nucleic acid amplification market by 2030. For instance, according to the 2022 edition of Health at a Glance, cancer is the second greatest reason for death in the EU behind cardiovascular disorders.
Between 30-50% of cancer patients' deaths are avoidable and mortality can also be reduced through earlier detection and the condition of better punctual and effective therapies. Europe's Beating Cancer Plan strives to decrease the load of cancer and manage cancer-related imbalances between and within nations, with efforts to help, coordinate and complete the actions of Member States.
The major global players in the market include: bioMerieux, Becton, Dickinson & Company, Lucigen, Qiagen, Quidel Corporation, Eiken Chemical Co. Ltd, Tecan Genomics Inc., Meridian Bioscience, OptiGene Limited and Thermo Fisher Scientific among others.
The Global Isothermal Nucleic Acid Amplification Technology Market Report Would Provide Approximately 53 Tables, 54 Figures and 195 pages.
LIST NOT EXHAUSTIVE